Jane Street Group, LLC Chimerix Inc Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$1.34 - $5.34 $19,966 - $79,566	-14,900 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$4.58 - $6.8 $62,746 - $93,160	-13,700 Reduced 47.9%	14,900 $68,000
Q4 2021 Feb 15, 2022	BUY	$5.23 - $7.18 $30,334 - $41,644	5,800 Added 25.44%	28,600 $184,000
Q3 2021 Nov 16, 2021	BUY	$5.94 - $8.75 $135,432 - $199,500	22,800 New	22,800 $141,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.